Novavax in Podcasts
companyNovavax, a biotechnology company developing vaccines and therapeutics.
1
mentions
Mentions in Podcasts
NPR News Now
NPR News: 05-31-2025 5PM EDT
The FDA approved the new vaccine for adults 65 and older and also for people aged 12 to 64 who are at higher risk from the coronavirus. That's the same limit that the FDA set in licensing another vaccine option from Novavax. When people get a scratch or an infection, the body responds better if it happens during the day. NPR's Burleigh McCoy reports on how the immune system tells time.